Cardiovascular Clinical Trials 2023

Browse 100 Cardiovascular Medical Studies Across 359 Cities
13 Phase 3 Trial · 727 Cardiovascular Clinics

Display Results

AllMost EffectiveMost SafeSenior FriendlyPediatricNo Placebo

Clinical Trials Cardiovascular Clinical Trials 2023

Reviewed by Michael Gill, B. Sc.

Image of University of Kansas Medical Center in Kansas City, United States.

High Intensity, Interval Exercise (HIIT)for Stroke

Kansas City, KS

This trial will study the best exercise to help stroke survivors improve their aerobic fitness and brain health.

University of Kansas Medical CenterSandra A Billinger, PhD

Image of Department of Rehabilitation Sciences at University at Buffalo in Buffalo, United States.

One Bout Of Moderate-intensity Sub-maximal Aerobic Exercisefor Spinal Cord Injury

This trial is investigating whether individuals with spinal cord injury have more cardiac, cerebrovascular, and cognitive dysfunction than non-injured people, and if one session of moderate aerobic exercise can improve these functions.

Department of Rehabilitation Sciences at University at BuffaloWenjie Ji, MS

Image of Texas Health Presbyterian Hospital Dallas in Dallas, United States.

Very Hot And Dryfor Hyperthermia

This trial studies how cooling helps reduce heart strain from summer heat waves in elderly people.

Texas Health Presbyterian Hospital Dallas

Image of Penn State Milton S. Hershey Medical Center in Hershey, United States.

Angiotensin-(1-7)for Aging

This trial will test whether angiotensin-(1-7), a hormone that protects against the renin-angiotensin system, can reduce the risk of cardiovascular disease in older adults by reducing sympathetic outflow and blood pressure and improving endothelial function.

Penn State Milton S. Hershey Medical CenterAmy C Arnold, PhD

Image of CUIMC in New York, United States.

BLB Interventionfor Acute Coronary Syndrome

This trial will test a "combined chronotherapy" intervention consisting of morning bright light therapy and evening blue light blocking, administered daily for 4 weeks in patients who experienced acute coronary syndrome. The primary aims are study feasibility, acceptability, appropriateness, and usability.

CUIMCAri Shechter, PhD

Image of Oregon Health and Science University in Portland, United States.

Circadian Protocolfor High Blood Pressure

This trial looks at how sleep and the body's natural 24-hour clock affects blood pressure in people with hypertension.

Oregon Health and Science UniversitySaurabh S Thosar, PhD

Image of UCLA Medical Center in Los Angeles, United States.

Mirtazapinefor Drug Interaction

Los Angeles, CA

This trial will study the effects of the drug mirtazapine on methamphetamine users. It will test if the drug alters the cardiovascular response or the pharmacokinetics of methamphetamine. The trial will also study if these effects are different in methamphetamine users who also use opioids.

FDA Approved Drug

UCLA Medical Center (+2 Sites)Phillip Coffin, MD, MIA

Image of Los Robles Regional Medical Center in Thousand Oaks, United States.

ReSept ASD Occluderfor Congenital Heart Defects

Thousand Oaks, CA

This trial is testing a new device to treat patients with a heart condition called atrial septal defect. The device will be used to close the hole in the heart and the trial will evaluate the safety and efficacy of the device.

Los Robles Regional Medical Center (+19 Sites)Larry Latson, MDatHeart Medical

Image of Nationwide Children's Hospital in Columbus, United States.

Tissue Engineered Vascular Graftsfor Congenital Heart Defects

This trial is testing a new type of surgery for people with heart problems. The new surgery is called "extracardiac total cavopulmonary connection." This trial is testing to see if the new surgery is safe and if it works well.

Nationwide Children's HospitalMark Galantowicz, MD

Image of Northwestern University in Chicago, United States.

Carvedilolfor Breast Cancer

This trial is studying a new way to prevent heart problems in breast cancer patients who are at risk for developing them from their chemotherapy.

Waitlist Available

FDA Approved Drug

Northwestern University

10 Cardiovascular Clinical Trials Near Me

Top Hospitals for Cardiovascular Clinical Trials

Image of Excel Medical Clinical Trials in Florida.

Excel Medical Clinical Trials

Boca Raton

4Active Trials

0All Time Trials for Cardiovascular

2022First Cardiovascular Trial

Image of University of Kansas Medical Center in Kansas.

University of Kansas Medical Center

Kansas City

3Active Trials

0All Time Trials for Cardiovascular

2015First Cardiovascular Trial

Image of Vanderbilt University in Tennessee.

Vanderbilt University

Nashville

3Active Trials

0All Time Trials for Cardiovascular

2021First Cardiovascular Trial

Image of York Clinical Research LLC in Virginia.

York Clinical Research LLC

Norfolk

3Active Trials

0All Time Trials for Cardiovascular

2022First Cardiovascular Trial

Image of Westside Medical Associates of Los Angeles in California.

Westside Medical Associates of Los Angeles

Beverly Hills

3Active Trials

0All Time Trials for Cardiovascular

2022First Cardiovascular Trial

Top Cities for Cardiovascular Clinical Trials

Image of Boston in Massachusetts.

Boston

11Active Trials

Massachusetts General HospitalTop Active Site

Image of Las Vegas in Nevada.

Las Vegas

11Active Trials

Palm Research Center IncTop Active Site

Cardiovascular Clinical Trials by Phase of Trial

N/A Cardiovascular Clinical Trials

65Active Cardiovascular Clinical Trials

63Number of Unique Treatments

135Number of Active Locations

Cardiovascular Clinical Trials by Age Group

< 65 Cardiovascular Clinical Trials

3Active Cardiovascular Clinical Trials

Mentoring Smartphone + Text Messaging with Health Coach Clinical Investigation

Most Recent Cardiovascular Clinical Trials

Clinical Trial

Began Recruiting Date

Phase

Budesonide-formoterol for Healthy Subjects

9/1/2023

Phase 1

High intensity, interval exercise (HIIT) for Stroke

7/1/2023

Phase 2

Orforglipron for Obesity

4/3/2023

Phase 3

melatonin for Healthy Subjects

1/1/2023

Phase 4

Olpasiran for Cardiovascular Disease

12/14/2022

Phase 3

Top Treatments for Cardiovascular Clinical Trials

Treatment Name

Active Cardiovascular Clinical Trials

All Time Trials for Cardiovascular

First Recorded Cardiovascular Trial

Intervention group

2

2

2023

Intervention

2

2

2023

Inclisiran sodium 300 mg

2

2

2021

Inclisiran

2

2

2018

High intensity, interval exercise (HIIT)

1

1

2023

About The Author

Michael Gill - B. Sc.

First Published: October 5th, 2021

Last Reviewed: September 8th, 2023

References¹ Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30. https://pubmed.ncbi.nlm.nih.gov/18929686² Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, Ogedegbe G, Orwig D, Ernst D, Czajkowski S; Treatment Fidelity Workgroup of the NIH Behavior Change Consortium. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004 Sep;23(5):443-51. https://pubmed.ncbi.nlm.nih.gov/15367063³ Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, Ogedegbe G, Orwig D, Ernst D, Czajkowski S; Treatment Fidelity Workgroup of the NIH Behavior Change Consortium. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004 Sep;23(5):443-51. doi: 10.1037/0278-6133.23.5.443. https://pubmed.ncbi.nlm.nih.gov/15367063⁴ James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20. doi: 10.1001/jama.2013.284427. Erratum In: JAMA. 2014 May 7;311(17):1809. https://pubmed.ncbi.nlm.nih.gov/24352797⁵ James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, Lackland DT, LeFevre ML, MacKenzie TD, Ogedegbe O, Smith SC Jr, Svetkey LP, Taler SJ, Townsend RR, Wright JT Jr, Narva AS, Ortiz E. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014 Feb 5;311(5):507-20. doi: 10.1001/jama.2013.284427. Erratum in: JAMA. 2014 May 7;311(17):1809. https://pubmed.ncbi.nlm.nih.gov/24352797⁶ Ngandu T, Lehtisalo J, Solomon A, Levalahti E, Ahtiluoto S, Antikainen R, Backman L, Hanninen T, Jula A, Laatikainen T, Lindstrom J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015 Jun 6;385(9984):2255-63. doi: 10.1016/S0140-6736(15)60461-5. Epub 2015 Mar 12. https://pubmed.ncbi.nlm.nih.gov/25771249⁷ Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015 Jun 6;385(9984):2255-63. doi: 10.1016/S0140-6736(15)60461-5. Epub 2015 Mar 12. https://pubmed.ncbi.nlm.nih.gov/25771249⁸ Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, Lindström J, Mangialasche F, Paajanen T, Pajala S, Peltonen M, Rauramaa R, Stigsdotter-Neely A, Strandberg T, Tuomilehto J, Soininen H, Kivipelto M. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015 Jun 6;385(9984):2255-63. doi: 10.1016/S0140-6736(15)60461-5. Epub 2015 Mar 12. https://pubmed.ncbi.nlm.nih.gov/25771249⁹ Volpp KG, Loewenstein G, Troxel AB, Doshi J, Price M, Laskin M, Kimmel SE. A test of financial incentives to improve warfarin adherence. BMC Health Serv Res. 2008 Dec 23;8:272. doi: 10.1186/1472-6963-8-272. https://pubmed.ncbi.nlm.nih.gov/19102784¹⁰ Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. https://pubmed.ncbi.nlm.nih.gov/27295427

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

Back to top

Terms of Service Privacy Policy Security